Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus - PubMed (original) (raw)

Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus

M F Liu et al. J Clin Immunol. 1998 Nov.

Abstract

CTLA-4 is a cell surface molecule expressed on activated T cells that is suggested to deliver a negative signal for T cell activation. Since CTLA-4 might be a negative regulator of autoimmune diseases, we investigated its expression on T cells from 20 patients with systemic lupus erythematosus (SLE) by flow cytometric analysis and RT-PCR. We found that although CTLA-4 mRNA was readily detected in all patients and controls, only a very minor subset of T cells expressed detectable surface CTLA-4 molecules in both groups. But patients with SLE had significantly increased percentages of CTLA-4-positive T cells compared with normal controls, implying at least that there was no apparent defective expression of CTLA-4 molecule in human lupus. The kinetics of CTLA-4 expression on T cells stimulated in vitro with PMA plus ionomycin were similar in normal controls and patients with SLE. The expression of CTLA-4 molecules after stimulation increased gradually and peaked at 72 hr. However, the induction of CTLA-4 expression on patients' T cells appeared to be weaker than that of normal individuals. Whether this reflects impaired downregulation by CTLA-4 molecules in SLE patients needs to be clarified further.

PubMed Disclaimer

Cited by

Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice.
Ichinose K, Zhang Z, Koga T, Juang YT, Kis-Tóth K, Sharpe AH, Kuchroo V, Crispín JC, Tsokos GC. Ichinose K, et al. Arthritis Rheum. 2013 Mar;65(3):764-9. doi: 10.1002/art.37790. Arthritis Rheum. 2013. PMID: 23203389 Free PMC article.
CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease.
Matsubara T, Anwar R, Fujiwara M, Ichiyama T, Furukawa S. Matsubara T, et al. Clin Exp Immunol. 2003 Apr;132(1):169-73. doi: 10.1046/j.1365-2249.2003.02109.x. Clin Exp Immunol. 2003. PMID: 12653853 Free PMC article.
Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.
Ayukawa H, Matsubara T, Kaneko M, Hasegawa M, Ichiyama T, Furukawa S. Ayukawa H, et al. Clin Exp Immunol. 2004 Jul;137(1):151-5. doi: 10.1111/j.1365-2249.2004.02502.x. Clin Exp Immunol. 2004. PMID: 15196256 Free PMC article.
Clinical manifestations and analyses of the cytotoxic T-lymphocyte associated-4 gene in two Japanese families with systemic lupus erythematosus.
Sugimoto K, Fujita S, Yanagida H, Shimada Y, Tabata N, Yagi K, Okada M, Takemura T. Sugimoto K, et al. Clin Exp Nephrol. 2008 Apr;12(2):149-154. doi: 10.1007/s10157-007-0019-0. Epub 2008 Jan 9. Clin Exp Nephrol. 2008. PMID: 18185908
Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.
Steiner K, Moosig F, Csernok E, Selleng K, Gross WL, Fleischer B, Bröker BM. Steiner K, et al. Clin Exp Immunol. 2001 Oct;126(1):143-50. doi: 10.1046/j.1365-2249.2001.01575.x. Clin Exp Immunol. 2001. PMID: 11678911 Free PMC article.

References

1. J Clin Invest. 1979 May;63(5):885-92 - PubMed
1. J Immunol. 1994 Aug 1;153(3):1378-85 - PubMed
1. Arthritis Rheum. 1996 Apr;39(4):600-9 - PubMed
1. J Clin Endocrinol Metab. 1997 Jan;82(1):143-6 - PubMed
1. J Exp Med. 1996 Jun 1;183(6):2541-50 - PubMed

Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus - PubMed (original) (raw)